PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for October 21, 2008 Subscribe to this News Feed    
 

LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers

LegalView reintroduced its Avandia practice area to include updated information for victims of the drug's side effects. Avandia has been linked to the development of early on-set osteoporosis and heart failure among patients.

Denver (PRWEB) October 21, 2008 -- LegalView.com, the most comprehensive legal resource available on the Web, recently re-launched its Avandia information portal to provide the most up-to-date news on potential Avandia side effects recently associated with patients taking the drug.

Those affected by the drug's side effects are advised to locate a pharmaceutical attorney as it may be necessary to develop an Avandia lawsuit to retrieve monetary compensation for the damages caused by the prescription drug.

Avandia (risiglitazone maleate) is a type 2 diabetes treatment from GlaxoSmithKline and was released in mid-1999. The drug was part of a new group of drugs that work to use the body's natural insulin to regulate blood glucose levels. In May 2007, the U.S. Food and Drug Administration (FDA) issued a health advisory for the drug, notating its potential risks for causing heart attacks and heart-related deaths among Avandia patients.

Additionally, in June 2007 the New England Journal of Medicine reported the severe dangers of heart failure among Avandia patients and found a 43 percent increase of heart attack among drug patients. Another study conducted by a group of Swiss researchers also found that those consuming Avandia were more likely to develop early on-set osteoporosis and bone fractures/bone breaks while taking the drug. Because of the Avandia risks of osteoporosis and heart failure it is important for Avandia patients to consult their physician if they feel that they may be at risk for developing any of the Avandia risks.

Type 2 diabetes is a serious and potentially fatal condition that is difficult to treat. According to the American Diabetes Association (ADA), several million Americans currently suffer from diabetes. Individuals who have the condition are at an increased risk for developing complications such as heart disease, kidney damage, blindness and nerve damage. Because of this potential for complications it becomes increasingly important and dangerous when prescription drugs, such as Avandia, add to the risk of causing diabetes complications. Individuals who have been given a prescription for Avandia should consult a physician immediately if they feel they may develop any of the drug's side effects. Additionally, contacting an Avandia law firm may be important to protect patients. Consulting a knowledgeable Avandia lawyer may provide insight into developing an Avandia class action lawsuit to retrieve monetary compensation for the damages caused by the drug.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U3F1YS1UaGlyLUluc2UtQ3Jhcy1JbnNlLVNpbmctWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Katie Kelley
LegalView
720-226-3614
Email us Here
Alan Haburchak
LegalView
720-226-3614
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move